Glucose-dependent insulinotropic polypeptide (GIP) receptor deletion leads to reduced bone strength and quality.

  title={Glucose-dependent insulinotropic polypeptide (GIP) receptor deletion leads to reduced bone strength and quality.},
  author={Aleksandra Mieczkowska and Nigel Irwin and Peter Raymond Flatt and Daniel Chappard and Guillaume Mabilleau},
  volume={56 2},
Bone is permanently remodeled by a complex network of local, hormonal and neuronal factors that affect osteoclast and osteoblast biology. In this context, a role for gastro-intestinal hormones has been proposed based on evidence that bone resorption dramatically falls after a meal. Glucose-dependent insulinotropic polypeptide (GIP) is one of the candidate hormones as its receptor, glucose-dependent insulinotropic polypeptide receptor (GIPR), is expressed in bone. In the present study we… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
24 Citations
36 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 24 extracted citations


Publications referenced by this paper.
Showing 1-10 of 36 references

Glucose-dependent insulinotropic polypeptide receptor deficiency leads to modifications of trabecualr bone mass and quality in mice

  • C Gaudin-Audrain, N Irwin, S Mansur, PR Flatt, B Thorens, M Baslé
  • Bone
  • 2013
1 Excerpt

Deficiency in glucose-dependent insulinotropic peptide receptor results in higher bone mass in male mice

  • G Mabilleau, C Gaudin-Audrain, N Irwin, PR Flatt, MF Basle, D. Chappard
  • Osteoporos Int 2012;23:S407–8
  • 2012

Similar Papers

Loading similar papers…